Xolair Perennial Allergy Panel
This panel may be useful to qualify patients for treatment with Xolair®. According to the package insert, only asthma patients who have IgE mediated disease should be treated with this drug. Patients can be qualified by skin test or in vitro IgE testing
see individual test information
2-3 business days from receipt of specimen
|Specimen Type||Order Code||CPT Code||NY Approved||Volume||Assay Range||Special Instructions|
|serum||402786P||86003 (x5), 82785 (x1)||Yes||
See Individual Test
Specimens are approved for testing in New York only when indicated in the Specimen Information field above.
The CPT codes provided are based on Viracor Eurofins' interpretation of the American Medical Association's Current Procedural Terminology (CPT) codes and are provided for general informational purposes only. CPT coding is the sole responsibility of the billing party. Questions regarding coding should be addressed to your local Medicare carrier. Viracor Eurofins assumes no responsibility for billing errors due to reliance on the CPT codes illustrated in this material.